Consulta’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156M Buy
+400,000
New +$169M 5.63% 10
2025
Q4
Sell
-150,000
Closed -$63.9M 15
2025
Q3
$63.9M Sell
150,000
-100,000
-40% -$38.8M 3.63% 11
2025
Q2
$95.8M Sell
250,000
-350,000
-58% -$126M 6.12% 7
2025
Q1
$207M Buy
600,000
+50,000
+9% +$16.1M 14.02% 3
2024
Q4
$165M Buy
550,000
+275,000
+100% +$96.1M 10.81% 4
2024
Q3
$112M Sell
275,000
-50,000
-15% -$18.3M 6.9% 7
2024
Q2
$104M Sell
325,000
-75,000
-19% -$24.4M 7.11% 6
2024
Q1
$133M Sell
400,000
-100,000
-20% -$30.6M 8.59% 3
2023
Q4
$135M Buy
500,000
+150,000
+43% +$37.1M 8.91% 4
2023
Q3
$86.1M Buy
350,000
+75,000
+27% +$20.5M 6.19% 9
2023
Q2
$83.5M Sell
275,000
-75,000
-21% -$20.9M 5.8% 11
2023
Q1
$92.3M Sell
350,000
-175,000
-33% -$44.5M 7.27% 7
2022
Q4
$126M Sell
525,000
-225,000
-30% -$50.4M 10.81% 4
2022
Q3
$138M Buy
750,000
+125,000
+20% +$24.9M 13.78% 1
2022
Q2
$105M Buy
625,000
+175,000
+39% +$37.6M 6.85% 9
2022
Q1
$113M Sell
450,000
-250,000
-36% -$62.8M 5.66% 9
2021
Q4
$180M Sell
700,000
-165,000
-19% -$40.4M 8.88% 5
2021
Q3
$210M Sell
865,000
-60,000
-6% -$14.7M 10.46% 6
2021
Q2
$191M Sell
925,000
-275,000
-23% -$56M 9.01% 6
2021
Q1
$226M Sell
1,200,000
-300,000
-20% -$52.9M 11.64% 5
2020
Q4
$247M Sell
1,500,000
-175,000
-10% -$25.6M 13.38% 3
2020
Q3
$209M Buy
1,675,000
+75,000
+5% +$9.28M 13.99% 2
2020
Q2
$155M Buy
1,600,000
+100,000
+7% +$10.4M 11.73% 2
2020
Q1
$135M Buy
1,500,000
+1,050,000
+233% +$136M 11.1% 4
2019
Q4
$66.5M Buy
450,000
+200,000
+80% +$26.9M 5.55% 8
2019
Q3
$30.1M Hold
250,000
2.59% 12
2019
Q2
$33.8M Hold
250,000
2.97% 11
2019
Q1
$32.6M Sell
250,000
-400,000
-62% -$53.7M 3.23% 10
2018
Q4
$80.9M Sell
650,000
-100,000
-13% -$13.4M 7.98% 4
2018
Q3
$104M Sell
750,000
-750,000
-50% -$93.4M 9.77% 3
2018
Q2
$154M Hold
1,500,000
15.31% 2
2018
Q1
$146M Hold
1,500,000
14.79% 3
2017
Q4
$132M Hold
1,500,000
15.56% 3
2017
Q3
$119M Buy
1,500,000
+100,000
+7% +$8.04M 15.98% 3
2017
Q2
$122M Buy
1,400,000
+275,000
+24% +$23.3M 14.86% 2
2017
Q1
$100M Sell
1,125,000
-125,000
-10% -$10.4M 12.11% 3
2016
Q4
$92.5M Sell
1,250,000
-170,000
-12% -$12.7M 11.79% 3
2016
Q3
$107M Buy
1,420,000
+70,000
+5% +$5.36M 14.03% 1
2016
Q2
$104M Hold
1,350,000
13.18% 2
2016
Q1
$105M Buy
1,350,000
+150,000
+13% +$10.5M 12.88% 2
2015
Q4
$81.2M Buy
1,200,000
+200,000
+20% +$14M 10.62% 5
2015
Q3
$77.4M Buy
+1,000,000
New +$88.5M 8.17% 7
2014
Q3
Sell
-1,087,996
Closed -$61.3M 14
2014
Q2
$61.3M Buy
+1,087,996
New +$57.4M 5.72% 10

Other funds holding HCA

Consulta's HCA Position: Q2 2026 in Review

Consulta opened a new position in HCA Healthcare (HCA) in Q2 2026: 400,000 shares worth $156M. The stake represents 5.63% of the portfolio and ranks #10 among its holdings. This is a return to the name: Consulta previously reported a position in HCA as recently as Q3 2025.

Consulta first reported a position in HCA in Q2 2014 and has held it in 43 quarters since. The position peaked at $247M in Q4 2020. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Consulta held 400,000 shares of HCA Healthcare worth $156M as of Q2 2026.
  • HCA Healthcare was a new Consulta position in Q2 2026.
  • HCA Healthcare made up 5.63% of Consulta's portfolio in Q2 2026, its #10 holding.
  • Consulta first reported a position in HCA Healthcare in Q2 2014 and has held it in 43 quarters since.
  • Consulta's HCA Healthcare position peaked at $247M in Q4 2020.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Consulta's 13F filing for Q2 2026, filed 14 Aug 2026.